These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20813131)

  • 1. The roles of TNF in brain dysfunction and disease.
    Clark IA; Alleva LM; Vissel B
    Pharmacol Ther; 2010 Dec; 128(3):519-48. PubMed ID: 20813131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches.
    Clark IA; Vissel B
    J Alzheimers Dis; 2021; 79(3):931-948. PubMed ID: 33459706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Curcumin in Regulation of TNF-α Mediated Brain Inflammatory Responses.
    Baj T; Seth R
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(1):69-77. PubMed ID: 29972106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease.
    McCoy MK; Tansey MG
    J Neuroinflammation; 2008 Oct; 5():45. PubMed ID: 18925972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral Tumor Necrosis Factor-Alpha (TNF-α) Modulates Amyloid Pathology by Regulating Blood-Derived Immune Cells and Glial Response in the Brain of AD/TNF Transgenic Mice.
    Paouri E; Tzara O; Kartalou GI; Zenelak S; Georgopoulos S
    J Neurosci; 2017 May; 37(20):5155-5171. PubMed ID: 28442538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The meteorology of cytokine storms, and the clinical usefulness of this knowledge.
    Clark IA; Vissel B
    Semin Immunopathol; 2017 Jul; 39(5):505-516. PubMed ID: 28451786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How TNF was recognized as a key mechanism of disease.
    Clark IA
    Cytokine Growth Factor Rev; 2007; 18(3-4):335-43. PubMed ID: 17493863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha in normal and diseased brain: Conflicting effects via intraneuronal receptor crosstalk?
    Perry SW; Dewhurst S; Bellizzi MJ; Gelbard HA
    J Neurovirol; 2002 Dec; 8(6):611-24. PubMed ID: 12476354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology.
    Rutsch A; Kantsjö JB; Ronchi F
    Front Immunol; 2020; 11():604179. PubMed ID: 33362788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bidirectional gut-brain-microbiota axis as a potential nexus between traumatic brain injury, inflammation, and disease.
    Sundman MH; Chen NK; Subbian V; Chou YH
    Brain Behav Immun; 2017 Nov; 66():31-44. PubMed ID: 28526435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury.
    Frugier T; Morganti-Kossmann MC; O'Reilly D; McLean CA
    J Neurotrauma; 2010 Mar; 27(3):497-507. PubMed ID: 20030565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARgamma as a therapeutic target in central nervous system diseases.
    Sundararajan S; Jiang Q; Heneka M; Landreth G
    Neurochem Int; 2006 Jul; 49(2):136-44. PubMed ID: 16766086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Neurologist's Guide to TNF Biology and to the Principles behind the Therapeutic Removal of Excess TNF in Disease.
    Clark IA; Vissel B
    Neural Plast; 2015; 2015():358263. PubMed ID: 26221543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumor necrosis factor-alpha in disease states and inflammation.
    Strieter RM; Kunkel SL; Bone RC
    Crit Care Med; 1993 Oct; 21(10 Suppl):S447-63. PubMed ID: 8403983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine toxicity to oligodendrocyte precursors is mediated by iron.
    Zhang X; Haaf M; Todorich B; Grosstephan E; Schieremberg H; Surguladze N; Connor JR
    Glia; 2005 Nov; 52(3):199-208. PubMed ID: 15968631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease.
    Holleran G; Lopetuso L; Petito V; Graziani C; Ianiro G; McNamara D; Gasbarrini A; Scaldaferri F
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28934123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting tumor necrosis factor alpha. New drugs used to modulate inflammatory diseases.
    LaDuca JR; Gaspari AA
    Dermatol Clin; 2001 Oct; 19(4):617-35. PubMed ID: 11705350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious disease-associated encephalopathies.
    Barbosa-Silva MC; Lima MN; Battaglini D; Robba C; Pelosi P; Rocco PRM; Maron-Gutierrez T
    Crit Care; 2021 Jul; 25(1):236. PubMed ID: 34229735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in clinical neurosciences: sepsis-associated encephalopathy: evolving concepts.
    Wilson JX; Young GB
    Can J Neurol Sci; 2003 May; 30(2):98-105. PubMed ID: 12774948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent roles for tumor necrosis factor-alpha in the brain.
    Sriram K; O'Callaghan JP
    J Neuroimmune Pharmacol; 2007 Jun; 2(2):140-53. PubMed ID: 18040839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.